The Effects of Platelet-Rich Plasma on Cell Proliferation and Adipogenic Potential of Adipose-Derived Stem Cells
Overview
Biomedical Engineering
Biotechnology
Affiliations
Background: Platelet-rich plasma (PRP) contains multiple growth factors and has been shown to enhance fat graft survival after lipotransfer. However, the molecular mechanisms mediating this effect remain unknown. Adipose-derived stem cells (ASCs) play an important role in fat graft survival and are a likely target for PRP-mediated effects. This study seeks to investigate the impact of PRP on ASC proliferation and adipogenic differentiation.
Methods: Human ASCs were isolated using our laboratory protocol. The experiments were divided into four arms: (1) ASCs cultured in general culture medium alone; (2) ASCs in general culture medium + 5%, 10%, 15%, or 20% PRP; (3) ASCs cultured in adipogenic differentiation medium alone; (4) ASCs cultured in adipogenic medium + 5%, 10%, 15%, or 20% PRP. Cell proliferation was analyzed and comparative m-RNA expression of adipogenic genes was assessed by quantitative PCR. Protein expression was determined by western blot.
Results: PRP significantly enhanced proliferation of ASCs, even in the presence of antiproliferative, proadipogenic media. In contrast, PRP inhibited adipogenic differentiation in adipogenic media, evidenced by decreased intracellular lipid accumulation and reduced adipogenic gene expression (PPAR-γ and FABP4). Inhibition appears to occur through downregulation of bone morphogenetic protein receptor IA (BMPRIA) and fibroblast growth factor receptor 1 (FGFR1). Interestingly, PRP elicited these effects across the entire range of doses studied.
Conclusions: PRP appears to modulate ASC function primarily by enhancing cell proliferation. The consequences of its impact on adipogenesis are less clear. Enhanced proliferation initially might set the stage for more robust regeneration and adipogenesis at later time points, providing an important target for ongoing research.
Vania R, Sanjaya I, Hamid A, Sudarsa S, Dewi I, Niryana I Narra J. 2025; 4(3):e1080.
PMID: 39816080 PMC: 11731649. DOI: 10.52225/narra.v4i3.1080.
Novel Advances in Cell-Free Therapy for Premature Ovarian Failure (POF): A Comprehensive Review.
Yahyavi Y, Kheradi N, Karimi A, Ebrahimi-Kalan A, Ramezani F, Yousefi S Adv Pharm Bull. 2024; 14(3):543-557.
PMID: 39494249 PMC: 11530876. DOI: 10.34172/apb.2024.059.
Janarthanan R, Jayakumar R, Iyer S J Funct Biomater. 2023; 14(8).
PMID: 37623654 PMC: 10455938. DOI: 10.3390/jfb14080409.
Analysis of Fat Graft Survival and Platelet-Rich Plasma Effects: The Transcriptomic Differences.
Yegin E, Yegin M, Kosova B, Gur E, Nuriyev U Cureus. 2023; 15(1):e34380.
PMID: 36874761 PMC: 9977076. DOI: 10.7759/cureus.34380.
Strategies to Improve AFT Volume Retention After Fat Grafting.
Liu M, Shang Y, Liu N, Zhen Y, Chen Y, An Y Aesthetic Plast Surg. 2022; 47(2):808-824.
PMID: 36316460 DOI: 10.1007/s00266-022-03088-y.